Journal of Clinical Epidemiology
Volume 54, Issue 12, Supplement 1 , Pages S61-S76, December 2001

Veterans aging cohort three-site study (VACS 3)

overview and description

  • S Smola

      Affiliations

    • Veterans Aging Cohort Study (VACS) Center, Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    • Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive C 11E-124 (130-U), Pittsburgh, PA 15240, USA
    • VA Health Services Research and Development Center of Excellence, Houston, TX, USA
  • ,
  • A.C Justice

      Affiliations

    • Veterans Aging Cohort Study (VACS) Center, Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    • Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive C 11E-124 (130-U), Pittsburgh, PA 15240, USA
    • Corresponding Author InformationCorresponding author. Tel.: 412-688-6957; fax: 412-688-6916. E-mail address:(A.C. Justice)
  • ,
  • J Wagner

      Affiliations

    • Veterans Aging Cohort Study (VACS) Center, Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
  • ,
  • L Rabeneck

      Affiliations

    • VA Health Services Research and Development Center of Excellence, Houston, TX, USA
    • Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    • VA Medical Center, Houston, TX, USA
  • ,
  • S Weissman

      Affiliations

    • Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
  • ,
  • M Rodriguez-Barradas

      Affiliations

    • Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    • VA Medical Center, Houston, TX, USA
  • ,
  • for the VACS 3 Project Team

Received 24 July 2001; received in revised form 17 August 2001; accepted 17 August 2001.

Abstract 

Outcomes for middle-aged and older individuals with HIV infection are poor, and are likely to be mediated by age-related differences in risks and resources (access to care, relationship with the provider, comorbid conditions, health habits, and changes brought about by aging). The goal of the Veterans Aging Cohort Three-Site Study (VACS 3) is to study the influence of age and mediating factors on outcomes with HIV in order to identify mutable mediators of poorer outcomes. VACS 3 is an observational, longitudinal study. Data sources include patient and provider surveys and electronic medical data collected at baseline and 12-month follow-up from the Infections Disease Clinics at three Veterans Affairs Medical Centers (Cleveland, OH, Houston, TX, and Manhattan, NY). Trained Survey Coordinators at each site determined which patients are HIV infected, obtained consent, and asked the patient to complete a questionnaire. The primary provider also completed a questionnaire. Twelve-month follow-up will be completed July 2001. Of all veterans with HIV seen in these clinics 85% (881) have consented and enrolled. Of the 881 corresponding provider surveys, 92% were completed. Mean age is 49; 55% are African-American; 38% of the sample were men who have sex with men; and less than 2% are women. Almost a third (32%) have been without a permanent address. Complimentary or alternative therapies are common as are the use of cigarettes, alcohol, and illicit drugs. The majority (87%) of the patients are taking multiple antiretroviral medications. The median CD4 count is 331 mm3, and the median viral load was 714 copies/ml. There is substantial variation by site. Veterans with HIV infection have characteristics that will likely become more prevalent among HIV-infected persons in the United States: they are older, commonly suffer comorbid disease, and are members of minority populations. VACS 3 may help inform the design of future clinical interventions to improve outcomes for people aging with HIV.

Keywords:  Veterans Aging Cohort Three-Site Study, Middle-aged individuals, HIV infection, Age-related differences

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Sharon Weissman was formerly with the VA Cleveland Medical Center, Cleveland, OH, and is currently at St. Raphael's Hospital, Yale University, New Haven, CT.

PII: S0895-4356(01)00448-6

Journal of Clinical Epidemiology
Volume 54, Issue 12, Supplement 1 , Pages S61-S76, December 2001